 double-blind placebo-controlled cytogenetic study oral acyclovir patients recurrent genital herpes antiherpes drug acyclovir breaks chromosomes vitro millimolar concentrations toxic doses rodents single-gene mutations Recurrent genital herpes patients chromosomal damage peripheral lymphocytes acute chronic acyclovir therapy Patients acyclovir recurrences placebo recurrences recurrences equal group treatment double-blind Normal volunteers acyclovir-treated cultures additional controls Cytogenetic analyses enrollment pretreatment day acute acyclovir placebo treatment first postenrollment recurrence postacute end year study postchronic Cells metaphase patient time point structural numerical chromosomal abnormalities No cytogenetic effects chronic acute oral acyclovir treatment relative controls pretreatment controls placebo treatment